The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study

• Asıl Yazarlar: Kultigin Turkmen (Yazar), Aydın Guclu (Yazar), Garip Sahin (Yazar), Ismail Kocyigit (Yazar), Levent Demirtas (Yazar), Fatih Mehmet Erdur (Yazar), Erkan Sengül (Yazar), Oktay Ozkan (Yazar), Habib Emre (Yazar), Faruk Turgut (Yazar), Hilmi Unal (Yazar), Murat Karaman (Yazar), Cengiz Acıkel (Yazar), Hasan Esen (Yazar), Ebru Balli (Yazar), Gulfidan Bıtırgen (Yazar), Halil Zeki Tonbul (Yazar), Mahmut Ilker Yılmaz (Yazar), Alberto Ortiz (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Karger Publishers, 2016-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background/Aims: Fabry disease is a treatable cause of chronic kidney disease (CKD) characterized by a genetic deficiency of α-galactosidase A. European Renal Best Practice (ERBP) recommends screening for Fabry disease in CKD patients. However, this is based on expert opinion and there are no report...